SCHEMBL27695517

SCHEMBL27695517

CC(=O)C[C@@H](Cc1ccccc1F)OC(=O)NC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSS P25774 1/20 0.42
▸ CTSK P43235 1/20 0.42
▸ RIPK1 Q13546 2/20 0.39
▸ TACR1 P25103 1/20 0.37
▸ TACR3 P29371 1/20 0.37
▸ ANO1 Q5XXA6 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.36
▸ MAOB P27338 1/20 0.36
▸ LMNA P02545 3/20 0.36
▸ PPARG P37231 1/20 0.36
▸ PPARA Q07869 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ TAAR1 Q96RJ0 2/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ SCN9A Q15858 2/20 0.35
▸ PTPN1 P18031 1/20 0.35
▸ ADRB2 P07550 1/20 0.34
▸ ADRB1 P08588 1/20 0.34
▸ ADRB3 P13945 1/20 0.34
▸ VNN1 O95497 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27689604 0.73 ALDH1A1 (0.51) RIPK1TACR1ANO1ALDH1A1MAOB
SCHEMBL29253769 0.72 RIPK1 (0.50) CTSSCTSKRIPK1TACR1TACR3
SCHEMBL29253671 0.72 RIPK1 (0.50) CTSSCTSKRIPK1TACR1TACR3
SCHEMBL4663069 0.72 CTSS (0.57) CTSSCTSKSCN9APTPN1
SCHEMBL890178 0.71 CTSS (0.42) CTSSCTSKALDH1A1MAOBLMNA
SCHEMBL19544604 0.70 TAAR1 (0.41) RIPK1ALDH1A1MAOBLMNAPPARG
SCHEMBL14282769 0.69 DPP4 (0.54) —
SCHEMBL29060746 0.69 CTSK (0.47) CTSSCTSKTACR3SCN9AMAPT
SCHEMBL14716956 0.68 CTSK (0.49) CTSSCTSKTACR3ALDH1A1SCN9A
SCHEMBL19544601 0.68 RIPK1 (0.40) CTSSCTSKRIPK1ALDH1A1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101005835-A 1-[(3r)-amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2r)-carboxylic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase iv (dpp-iv) inhibitors for the treatment of type 2 diab SANTHERA PHARMACEUTICALS CH (CH) 2007-07-25 — — CN disclosed
Send feedback